Načítá se...
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59(®)‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons
BACKGROUND: In Europe, the enhanced safety surveillance (ESS) of seasonal influenza vaccines is mandatory, in order to detect any potential increase in reactogenicity when the vaccine composition is updated. The MF59(®)‐adjuvanted influenza vaccine (Fluad™) is the first and the only licensed adjuvan...
Uloženo v:
| Vydáno v: | Influenza Other Respir Viruses |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6928029/ https://ncbi.nlm.nih.gov/pubmed/31617965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12685 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|